These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1947366)

  • 1. Steroid trials in the assessment of reversibility of air flow limitation: a survey of current clinical practice of chest physicians.
    Wiggins J; Feher MD; Lant AF; Collins JV
    Respir Med; 1991 Jul; 85(4):295-9. PubMed ID: 1947366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trials of steroids in patients with chronic airflow obstruction.
    Rudolf M
    Postgrad Med J; 1983; 59 Suppl 3():68-70. PubMed ID: 6359111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
    Nisar M; Walshaw M; Earis JE; Pearson MG; Calverley PM
    Thorax; 1990 Mar; 45(3):190-4. PubMed ID: 2330551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of serial peak expiratory flow measurements in assessing treatment response in chronic airflow limitation.
    Mitchell DM; Gildeh P; Dimond AH; Collins JV
    Thorax; 1986 Aug; 41(8):606-10. PubMed ID: 3538487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prednisolone in chronic airflow limitation.
    Mitchell DM; Gildeh P; Rehahn M; Dimond AH; Collins JV
    Lancet; 1984 Jul; 2(8396):193-6. PubMed ID: 6146752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Corticosteroid therapy test in the evaluation of the reversibility of respiratory airways obstruction].
    Dangubić V; Vukov N; Jovanović D; Mrda V; Jokanović D
    Vojnosanit Pregl; 1984; 41(3):184-7. PubMed ID: 6495674
    [No Abstract]   [Full Text] [Related]  

  • 7. Additive effects of prednisolone and beclomethasone dipropionate in patients with stable chronic obstructive pulmonary disease.
    Nishimura K; Ikeda A; Koyama H; Zhang M; Tsukino M; Hajiro T; Izumi T
    Pulm Pharmacol Ther; 2000; 13(5):225-30. PubMed ID: 11001866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of steroid responsiveness in patients with chronic airflow obstruction.
    Stokes TC; Shaylor JM; O'Reilly JF; Harrison BD
    Lancet; 1982 Aug; 2(8294):345-8. PubMed ID: 6124757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate.
    Weir DC; Gove RI; Robertson AS; Burge PS
    Thorax; 1990 Feb; 45(2):112-7. PubMed ID: 2180105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral corticosteroid trials in the management of stable chronic obstructive pulmonary disease.
    Davies L; Nisar M; Pearson MG; Costello RW; Earis JE; Calverley PM
    QJM; 1999 Jul; 92(7):395-400. PubMed ID: 10627889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effects of prednisolone and mianserin on ventilatory, exercise and psychometric parameters in patients with chronic obstructive pulmonary disease.
    Grove A; Lipworth BJ; Ingram CG; Clark RA; Dhillon DP
    Eur J Clin Pharmacol; 1995; 48(1):13-8. PubMed ID: 7621841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid responsiveness and chronic airflow obstruction.
    Rudd R; Gellert A; Empey D
    Lancet; 1982 Oct; 2(8302):820. PubMed ID: 6126688
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind comparison of oral prednisolone 40 mg/day with inhaled beclomethasone dipropionate 1500 ug/day in patients with adult onset chronic obstructive airways disease.
    Robertson AS; Gove RI; Wieland GA; Burge PS
    Eur J Respir Dis Suppl; 1986; 146():565-9. PubMed ID: 3465581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease.
    Papi A; Romagnoli M; Baraldo S; Braccioni F; Guzzinati I; Saetta M; Ciaccia A; Fabbri LM
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1773-7. PubMed ID: 11069811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of corticosteroids in the management of chronic obstructive lung disease: factors predicting response.
    Goel A; Suri JC; Aggarwal K
    Indian J Chest Dis Allied Sci; 1992; 34(1):11-7. PubMed ID: 1521875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis.
    Pantin CF; Stead RJ; Hodson ME; Batten JC
    Thorax; 1986 Jan; 41(1):34-8. PubMed ID: 3518129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological changes and improvement in chronic airflow limitation after corticosteroid treatment.
    Mitchell DM; Gildeh P; Rehahn M; Dimond A; Collins JV
    Thorax; 1984 Dec; 39(12):924-7. PubMed ID: 6393417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compliance with oral corticosteroids during steroid trials in chronic airways obstruction.
    Hatton MQ; Allen MB; Vathenen SV; Feely MP; Cooke NJ
    Thorax; 1996 Mar; 51(3):323-4. PubMed ID: 8779142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation.
    Morrison JF; Jones PC; Muers MF
    Eur Respir J; 1992 Apr; 5(4):424-9. PubMed ID: 1532940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose response relation to oral theophylline in severe chronic obstructive airways disease.
    Chrystyn H; Mulley BA; Peake MD
    BMJ; 1988 Dec; 297(6662):1506-10. PubMed ID: 3147048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.